Effectiveness of a pharmacy care management program for veterans with dyslipidemia

Pharmacotherapy

Volumn 33, Issue 7, 2013, Pages 736-743

  Smith, Michael C ^a   Boldt, Amy S ^a   Walston, Cassandra M ^a   Zillich, Alan J ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Care management; Clinical pharmacist; Disease management; Dyslipidemia; Hyperlipidemia; Outcomes; Veterans

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SERVICE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PHARMACIST ATTITUDE; PROFESSIONAL COMPETENCE; PROFESSIONAL KNOWLEDGE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; VETERAN;

CARE MANAGEMENT; CLINICAL PHARMACIST; DISEASE MANAGEMENT; DYSLIPIDEMIA; HYPERLIPIDEMIA; OUTCOMES; VETERANS;

AGED; COHORT STUDIES; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, VETERANS; HUMANS; HYPOLIPIDEMIC AGENTS; LIPIDS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHARMACEUTICAL SERVICES; PHARMACISTS; PRIMARY HEALTH CARE; PROFESSIONAL ROLE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VETERANS;

EID: 84885403430     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/phar.1273     Document Type: Article

References (27)

1. Pederson TR, Kjekshus J, Berg K, Haghfelt T, Faergeman O, Thorgeirsson G, et al. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344(8934): 1383-9.
2. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106(31):43-421.
3. Fera T, Bluml BM, Ellis WM. Diabetes Ten City Challenge: final economic and clinical results. J Am Pharm Assoc 2009;49:e52-60.
4. Bunting BA, Smith BH, Sutherland SE. The Asheville Project: clinical and economic outcomes of a community-based longterm medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc 2008;48:23-31.
5. Bryant LJM, Coster G, Gamble GD, McCormick RN. The General Practitioner-Pharmacist Collaboration (GPPC) study: a randomized controlled trial of clinical medication reviews in community pharmacy. IJPP 2011;19:94-105.
6. O'Donnell D, Chen NT, Piziak VK. Goal attainment and maintenance of serum cholesterol level in a pharmacist-coordinated lipid clinic. Am J Health Syst Pharm 2001;58:325-30.
7. Straka R, Taheri R, Cooper S, Smith J. Achieving Cholesterol Target in a Managed Care Organization (ACTION) Trial. Pharmacotherapy 2005;25(3):360-71.
8. Olson KL, Rasmussen J, Sandhoff BG, Merenich JA. Lipid management in patients with coronary artery disease by a clinical pharmacy service in a group model health maintenance organization. Arch Intern Med 2005;165:49-54.
9. Olson KL, Delate T, Rasmussen J, Humphries TL, Merenich JA. Outcomes of patients discharged from pharmacy-managed cardiovascular disease management. Am J Manag Care 2009;15 (8):497-503.
10. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1425-35.
11. Pederson TR, Faergeman O, Kastelein JP, et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction. JAMA 2005;294(19):2437-45.
12. Upadhyay UD, Waddell EN, Young S, et al. Prevalence, awareness, treatment, and control of high LDL cholesterol in New York City, 2004. Prev Chronic Dis 2010;7(3):A61.
13. Massing MW, Foley KA, Carter-Edwards L, Sueta CA, Alexander CM, et al. Disparities in lipid management for African Americans and Caucasians with coronary artery disease: a national cross-sectional study. BMC Cardiovascular Disorders 2004;4:15.
14. Gomez-Soto FM, Romero SP, et al. Mortality and morbidity of newly diagnosed heart failure treated with statins: a propensity- adjusted cohort study. Int J Cardiol 2010;140:210-8.
15. Geurts MM, Talsma J, et al. Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. Br J Clin Pharmacol 2012;74(1):16-33.
16. Dey RM, de Vries MJW, Bosnic-Anticevich S. Collaboration in chronic care: unpacking the relationship of pharmacists and general medical practitioners in primary care. IJPP 2011;19:21-9.
17. Ford ES, Li C, Pearson WS, Zhao G, Mokdad AH. Trends in hypercholesterolemia, treatment and control among United States adults. Int J Cardiol 2010;140:226-35.
18. Mazzolini TA, Irons BK, Schell EC, Seifert CF. Lipid levels and use of lipid-lowering drugs for patients in pharmacistmanaged lipid clinics versus usual care in 2 VA medical centers. J Manag Care Pharm 2005;11(9):763-71.
19. Till L, Voris J, Horst J. Assessment of clinical pharmacist management of lipid-lowering therapy in a primary care setting. JMCP 2003;3:269-73.
20. Ellis SL, Carter BL, Malone DC, et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy 2000;20:1508-16.
21. Charrois TL, Zolezzie M, et al. A systematic review of the evidence for pharmacist care of patients with dyslipidemia. Pharmacotherapy 2012;32(3):222-33.
22. Smith M, Bates DW, Bodenheimer T, Cleary T. Why pharmacists belong in the medical home. Health Aff 2010;29:906-13.
23. Carroll MD, Kit BK, Lacher DA. Total and High-density Lipoprotein Cholesterol in Adults: National Health and Nutrition Examination Survey 2009-2010: NCHS data brief no 92 Hyattsville, MD: National Center for Health Statistics, 2012.
24. Centers for Disease Control and Prevention. Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol-United States-1999-2000 and 2005- 2008. MMWR 2011;60(04):109-14.
25. Santschi V, Chiolero A, Burnand B, Colosimo AL, Paradis G. Impact of pharmacist care in the management of cardiovascular disease risk factors. Arch Intern Med 2011;171(16):1441-53.
26. Pirraglia PA, Rowland E, et al. Benefits of a primary care clinic co-located and integrated in a mental health setting for veterans with serious mental illness. Prev Chronic Dis 2012;9:110-3.
27. Chisolm-Burns MA, Lee JK, Spivey CA, et al. US pharmacists' effect as team members on patient care: systematic review and meta-analysis. Med Care 2010;48:923-33.